| Dr William Robert Howard, MD | |
|
400 Fairview Ave, Suite 16, Ponca City, OK 74601-1920 | |
| (580) 762-8324 | |
| (580) 762-2581 |
| Full Name | Dr William Robert Howard |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 400 Fairview Ave, Ponca City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316008675 | NPI | - | NPPES |
| 582628 | Other | KS | BCBS-KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | OK10717 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Robert Howard, MD 400 Fairview Ave, Suite 16, Ponca City, OK 74601-1920 Ph: (580) 762-8324 | Dr William Robert Howard, MD 400 Fairview Ave, Suite 16, Ponca City, OK 74601-1920 Ph: (580) 762-8324 |
News Archive
Advanced Medical Diagnostics SA, a privately held company committed to providing innovative computer-aided solutions (HistoScanning™) that improve the diagnostic interpretation of ultrasound scans, today announced a collaboration with the BUND-DER-UROLOGEN for the opening of 15 Tissue Differentiation Diagnostic Centres.
LUNGevity Foundation is honored to announce a grant of $250,000 from Bristol-Myers Squibb for the development of educational materials on immuno-oncology. Progress in understanding lung cancer and treatment approaches has accelerated dramatically in the past several years after many slow decades.
Researchers have developed a new scoring system that may better identify adolescents with the metabolic syndrome, a group at increased risk of later developing Type 2 diabetes and heart disease.
VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be featured in a total of six presentations – including an oral presentation, three moderated poster presentations and two poster presentations – during the 70th Scientific Sessions of the American Diabetes Association, being held from June 25-29, 2010 in Orlando, Florida.
Central line associated bloodstream infections (CLABSIs) in newborns were reduced by 58 percent in less than a year in hospital neonatal intensive care units (NICUs) participating in an Agency for Healthcare Research and Quality patient safety program.
› Verified 8 days ago
James Michael Rebik, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 421 E. Hartford Ave., Ponca City, OK 74601 Phone: 580-718-4502 Fax: 580-765-2123 |